Table 3.
NCI responses at respective assessment time points and best response achieved for all patients
| No. on Rx/ITT | Evaluation cycle |
||||
|---|---|---|---|---|---|
| 3 cycles, no. (%) 54/60* | 9 cycles, no. (%) 43/60 | 15 cycles, no. (%) 38/60 | 21 cycles, no. (%) 35/60 | Best response, no. (%) 60 | |
| Response † | |||||
| CR | 0 | 1 (2) | 3 (5) | 5 (8) | 6 (10) |
| CRi | 0 | 0 | 2 (3) | 3 (5) | 3 (5) |
| nPR | 0 | 6 (10) | 4 (7) | 5 (8) | 4 (7) |
| PR | 24 (40) | 27 (45) | 27 (45) | 22 (37) | 26 (43) |
| ORR | 24 (40) | 34 (57) | 36 (60) | 35 (58) | 39 (65) |
| DC(PR) | 0 | 1 | 0 | 1 | |
Rx indicates therapy; ITT, intention-to-treat; nPR, nodular partial response; and DC(PR), discontinued in PR.
One patient not evaluable.
2008 NCI working group criteria for response.